NPPB and hydrops fetalis: Of note, NT-proBNP is not a direct substrate for neprylisin inhibition; as such the decrease in its levels makes it the preferred biomarker for monitoring HF patients treated with sacubitril/valsartan, especially during the first 10 weeks, when the increase in BNP levels is maximum [74,75,76,87].